BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 28080998)

  • 1. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases.
    Pantano F; Brauneis S; Forneris A; Pacifici R; Marinelli E; Kyriakou C; Pichini S; Busardò FP
    Clin Chem Lab Med; 2017 Aug; 55(9):1324-1331. PubMed ID: 28080998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry.
    Gaudette F; Sirhan-Daneau A; St-Onge M; Turgeon J; Michaud V
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():174-180. PubMed ID: 26655109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of oxycodone, noroxycodone and oxymorphone by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry in human matrices: in vivo and in vitro applications.
    Fang WB; Lofwall MR; Walsh SL; Moody DE
    J Anal Toxicol; 2013; 37(6):337-44. PubMed ID: 23743505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry.
    Neuvonen M; Neuvonen PJ
    Ther Drug Monit; 2008 Jun; 30(3):333-40. PubMed ID: 18520605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of liquid chromatography/mass spectrometry for quantitative analysis of oxycodone, oxymorphone and noroxycodone in Ringer solution, rat plasma and rat brain tissue.
    Boström E; Jansson B; Hammarlund-Udenaes M; Simonsson US
    Rapid Commun Mass Spectrom; 2004; 18(21):2565-76. PubMed ID: 15468158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level quantitation of oxycodone and its oxidative metabolites, noroxycodone, and oxymorphone, in rat plasma by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Edwards SR; Smith MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):264-70. PubMed ID: 17098487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of oxycodone and its major metabolites in haematic and urinary matrices: Comparison of traditional and miniaturised sampling approaches.
    Protti M; Catapano MC; Samolsky Dekel BG; Rudge J; Gerra G; Somaini L; Mandrioli R; Mercolini L
    J Pharm Biomed Anal; 2018 Apr; 152():204-214. PubMed ID: 29414014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of polar analytes using column-switching: application to oxycodone and three metabolites in human plasma.
    Wagner M; Bourgogne E; Varesio E; Hopfgartner G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Mar; 878(7-8):637-44. PubMed ID: 20138595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous LC-MS/MS quantification of oxycodone, tramadol and fentanyl and their metabolites (noroxycodone, oxymorphone, O- desmethyltramadol, N- desmethyltramadol, and norfentanyl) in human plasma and whole blood collected via venepuncture and volumetric absorptive micro sampling.
    Al-Qurain AA; Williams DB; Mackenzie L; Roberts MS; Wiese MD
    J Pharm Biomed Anal; 2021 Sep; 203():114171. PubMed ID: 34087551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives.
    Cone EJ; Zichterman A; Heltsley R; Black DL; Cawthon B; Robert T; Moser F; Caplan YH
    Forensic Sci Int; 2010 May; 198(1-3):58-61. PubMed ID: 20036472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in the pharmacokinetics, oxidative metabolism and oral bioavailability of oxycodone in the Sprague-Dawley rat.
    Chan S; Edwards SR; Wyse BD; Smith MT
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):295-302. PubMed ID: 17973932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations of urinary oxycodone and metabolite distributions in pain patients.
    Elder NM; Atayee RS; Best BM; Ma JD
    J Anal Toxicol; 2014 Apr; 38(3):129-34. PubMed ID: 24523296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of morphine, oxycodone, morphine-3-glucuronide, and noroxycodone concentrations in rat serum by high performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Edwards SR; Smith MT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):241-9. PubMed ID: 15639445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring oxycodone use in patients with chronic pain: analysis of oxycodone and metabolite excretion in saliva and urine.
    Moy KV; Ma JD; Morello CM; Atayee RS; Best BM
    J Opioid Manag; 2014; 10(1):47-56. PubMed ID: 24604569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid quantification of urinary oxycodone and oxymorphone using fast gas chromatography-mass spectrometry.
    McKinley S; Snyder JJ; Welsh E; Kazarian CM; Jamerson MH; Klette KL
    J Anal Toxicol; 2007 Oct; 31(8):434-41. PubMed ID: 17988456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) for determination of GHB, precursors and metabolites in different specimens: Application to clinical and forensic cases.
    Busardò FP; Kyriakou C; Marchei E; Pacifici R; Pedersen DS; Pichini S
    J Pharm Biomed Anal; 2017 Apr; 137():123-131. PubMed ID: 28110168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
    Heltsley R; Zichterman A; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
    J Anal Toxicol; 2010; 34(1):32-8. PubMed ID: 20109300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects.
    Pöyhiä R; Seppälä T; Olkkola KT; Kalso E
    Br J Clin Pharmacol; 1992 Jun; 33(6):617-21. PubMed ID: 1389934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sensitive LC-MS/MS method for the quantitation of oxycodone, noroxycodone, 6α-oxycodol, 6β-oxycodol, oxymorphone, and noroxymorphone in human blood.
    Truver MT; Jakobsson G; Chermà MD; Swortwood MJ; Gréen H; Kronstrand R
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122625. PubMed ID: 33744597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
    Stamer UM; Zhang L; Book M; Lehmann LE; Stuber F; Musshoff F
    PLoS One; 2013; 8(3):e60239. PubMed ID: 23555934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.